696614-18-3

Upstream product

• 111-26-2 hexan-1-amine 
• 163878-18-0 (+)-(1S,2R,4R,6R)-2,4-Bis(benzyloxy)-1,6-epoxycyclohexane 
• 501-53-1 benzyl chloroformate 
• 627502-43-6 (-)-(1S,2R,4S,6R)-2,4-bis(benzyloxy)-6-hexylaminocyclohexanol 

Downstream Products

• 696614-52-5 (-)-(1S,2R,4S,6R)-(O¹-methylphosphonyl)-2,4-bis(benzyloxy)-N-benzyloxycarbonyl-6-hexylaminocyclohexanol 

Relevant academic research and scientific papers

Removal of the phosphate group in mechanism-based inhibitors of inositol monophosphatase leads to unusual inhibitory activity.

Inositol monophosphatase is widely held to be the therapeutic target for inhibition by lithium ion in the treatment of bipolar disorder. In a continued effort to improve the bioavailability of alternative inhibitors, we have designed and tested two new se